Effect of epidural analgesia with bupivacaine hydrochloride on neonatal bilirubin production.
We evaluated the rate of bilirubin production in vivo in newborns whose mothers received an epidural block with bupivacaine hydrochloride during labor and delivery. Bilirubin production was estimated in 23 full-term newborns whose mothers were treated with bupivacaine and in 20 controls by determining the end-tidal carbon monoxide concentration and the blood carboxyhemoglobin level corrected for ambient carbon monoxide. No significant difference was found between the mean end-tidal carbon monoxide concentrations for the bupivacaine-treated and the control groups (1.3 +/- 0.5 and 1.4 +/- 0.7 microL/kg/hour, respectively), or between the mean blood carboxyhemoglobin levels corrected for ambient carbon monoxide (0.54 +/- 0.17 and 0.52 +/- 0.18% saturation, respectively). These negative findings support the clinical studies, which have failed to demonstrate a causative connection between bupivacaine and neonatal jaundice.
D000767:Anesthesia, Epidural; D000773:Anesthesia, Obstetrical; D001663:Bilirubin / Q000097:blood*; D002045:Bupivacaine / Q000009:adverse effects*; D002245:Carbon Dioxide / Q000097:blood; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007567:Jaundice, Neonatal / Q000097:blood / Q000139:chemically induced*; D011247:Pregnancy
D002245:Carbon Dioxide; D001663:Bilirubin; D002045:Bupivacaine